Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F3FL7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,089
Award facts
- Contract value 100% obligated
- $15,089.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,089.49 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Cosentyx (secukinumab) 300mg dose-2 pen/ml pharmaceutical product. This non-set-aside, firm fixed-price delivery order has an ultimate completion date of January 13, 2026 and represents performance at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor specializing in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company competes on a full and open basis for federal contracts and has demonstrated extensive capability in fulfilling medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Cosentyx, a specialized immunology medication, exemplifies the contractor's role in providing critical pharmaceutical support to military treatment facilities and federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F3FL7?
SPE2DR26F3FL7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F3FL7 worth?
The government has obligated $15,089 on SPE2DR26F3FL7.
Is contract SPE2DR26F3FL7 an order under another contract?
Yes. SPE2DR26F3FL7 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FL7 competed?
The extent of competition for SPE2DR26F3FL7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award